Elizabeth Ochoa

Elizabeth Ochoa

Auto-generated profile, based on publicly available information

Elizabeth Ochoa

Sam and Ann Barshop Institute for Longevity and Aging Studies, San Antonio, TX, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2023 in Science Advances
Verified
Journal Article
Closed access
EOElizabeth Ochoa
Elizabeth Ochoa
PRPaulino Ramirez
Paulino Ramirez
EGElias Gonzalez
Elias Gonzalez
JMJasmine De Mange
Jasmine De Mange
WRWilliam J. Ray
William J. Ray
BFBess Frost
Bess Frost
Deposition of tau protein aggregates in the brain of affected individuals is a defining feature of “tauopathies,” including Alzheimer’s disease. Studies of human brain tissue and various model systems of tauopathy report that toxic forms of tau negatively affect nuclear and genomic architecture, identifying pathogenic tau–induced heterochromatin decondensation and consequent retrotransposon activation as a causal mediator of neurodegeneration. On the basis of their similarity to retroviruses, retrotransposons drive neuroinflammation via toxic intermediates, including double-stranded RNA (dsRNA). We find that dsRNA and dsRNA sensing machinery are elevated in astrocytes of postmortem brain tissue from patients with Alzheimer’s disease and progressive supranuclear palsy and in brains of tau transgenic mice. Using a Drosophila model of tauopathy, we identify specific tau-induced retrotransposons that form dsRNA and find that pathogenic tau and heterochromatin decondensation causally drive dsRNA-mediated neurodegeneration and neuroinflammation. Our study suggests that pathogenic tau–induced heterochromatin decondensation and retrotransposon activation cause elevation of inflammatory, transposable element–derived dsRNA in the adult brain.

17 October 2021 in Progress in Neurobiology
Verified
Journal Article
Open access
PRPaulino Ramirez
Paulino Ramirez
GZGabrielle Zuniga
Gabrielle Zuniga
WSWenyan Sun
Wenyan Sun
ABAdrian Beckmann
Adrian Beckmann
EOElizabeth Ochoa
Elizabeth Ochoa
BFBess Frost
Bess Frost
Transposable elements comprise almost half of the mammalian genome. A growing body of evidence suggests that transposable element dysregulation accompanies brain aging and neurodegenerative disorders, and that transposable element activation is neurotoxic. Recent studies have identified links between pathogenic forms of tau, a protein that accumulates in Alzheimer’s disease and related “tauopathies,” and transposable element-induced neurotoxicity. Starting with transcriptomic analyses, we find that age- and tau-induced transposable element activation occurs in the mouse brain. Among transposable elements that are activated at the RNA level in the context of brain aging and tauopathy, we find that the endogenous retrovirus (ERV) class of retrotransposons is particularly enriched. We show that protein encoded by Intracisternal A-particle, a highly active mouse ERV, is elevated in brains of tau transgenic mice. Using two complementary approaches, we find that brains of tau transgenic mice contain increased DNA copy number of transposable elements, raising the possibility that these elements actively retrotranspose in the context of tauopathy. Taken together, our study lays the groundwork for future mechanistic studies focused on transposable element regulation in the aging mouse brain and in mouse models of tauopathy and provides support for ongoing therapeutic efforts targeting transposable element activation in patients with Alzheimer’s disease.

31 December 2021 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
PDF file
ETElizabeth Ochoa Thomas
Elizabeth Ochoa Thomas
PRPaulino Ramirez
Paulino Ramirez
BHBradley T Hyman
Bradley T Hyman
WRWilliam J Ray
William J Ray
BFBess Frost
Bess Frost